“Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab”, Radiol Oncol, vol. 48, no. 2, May 2014, Accessed: Oct. 20, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/1999